Perfused, but not Leaking

Ophthalmology

Volumn 116, Issue 8, 2009, Pages

  Prenner, Jonathan L ^a   Kaiser, Richard ^a   Chang, Tom S ^a  

^a Wyndmoor ^*

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

ANGIOGRAPHY; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ACTIVITY; FIBROSIS; HUMAN; LASER COAGULATION; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; VASCULAR PATENCY; VISUAL ACUITY;

EID: 67949112906     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.007     Document Type: Letter

References (2)

1. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
2. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431